Australia markets closed

Phathom Pharmaceuticals, Inc. (PHAT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.81-0.31 (-3.38%)
As of 09:47AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts7777
Avg. Estimate-1.24-1.21-4.59-3.24
Low estimate-1.63-1.66-5.94-4.34
High estimate-1.01-0.81-3.34-2.17
Year ago EPS-0.89-0.84-3.93-4.59
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts7777
Avg. Estimate2.05M6.07M44.81M173.66M
Low estimate830k4.49M34M133.12M
High estimate3.5M7.35M53.9M237.34M
Year ago salesN/AN/A682k44.81M
Sales growth (year/est)N/AN/A6,470.40%287.50%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-1.26-0.98-0.89-1.08
Actual EPS-0.89-0.84-0.76-1.39
Difference0.370.140.13-0.31
Surprise %29.40%14.30%14.60%-28.70%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-1.24-1.21-4.59-3.24
7 days ago-1.22-1.19-4.57-3.21
30 days ago-1.22-1.19-4.56-3.21
60 days ago-1.24-1.22-4.56-3.14
90 days ago-1.26-1.23-4.54-3.06
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1N/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/A111
Growth estimatesPHATIndustrySector(s)S&P 500
Current qtr.-39.30%N/AN/AN/A
Next qtr.-44.00%N/AN/AN/A
Current year-16.80%N/AN/AN/A
Next year29.40%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A